文献速递关节外科创伤骨科

D-二聚体是肩关节假体周围感染的可靠血清标志物吗?

Is D-dimer a Reliable Serum Marker for Shoulder Periprosthetic Joint Infection?
PubMed 文献 · Clin Orthop Relat Res · 2021-01-01

该诊断性研究纳入94例翻修肩关节置换术前患者,按ICM定义分类感染可能性,评估D-二聚体对肩关节假体周围感染的诊断价值。D-二聚体在确定或很可能感染患者中升高,但AUC仅0.71,诊断价值弱;以598 ng/mL为阈值,敏感性61%、特异性74%。

要点

  • D-二聚体在确定或很可能肩关节假体周围感染患者中升高。
  • D-二聚体诊断肩关节假体周围感染的AUC为0.71,诊断价值弱。
  • 三项血清标志物均阳性时特异性88%,但敏感性降至28%。

核心结论

  • 在肩关节假体周围感染中,D-二聚体升高,但与其他血清学检查类似,其诊断效用有限。

研究设计与样本

  • 单中心诊断性研究,纳入2016年3月至2020年3月94例翻修全肩关节置换术前完成CRP、ESR和D-二聚体检测的患者。
  • 患者平均年龄69±8岁,56%(53/94)为男性。
  • 依据国际共识会议(ICM)定义将患者分类为确定、很可能、可能或不太可能感染。

主要发现

  • 确定或很可能感染患者D-二聚体中位数661 ng/mL(范围150至8205),可能或不太可能感染患者为263 ng/mL(范围150至3060),中位差143 ng/mL(95%CI 40至503),p=0.01。
  • ROC曲线分析显示D-二聚体AUC为0.71(0.50-0.92),诊断价值弱。
  • D-二聚体阈值598 ng/mL诊断确定或很可能感染的敏感性为61%(95%CI 36%至82%),特异性为74%(95%CI 62%至83%)。
  • 三项血清标志物(ESR、CRP和D-二聚体)均阳性时,检测假体周围关节感染的特异性为88%(95%CI 79%至94%),敏感性为28%(95%CI 10%至53%)。

关键数值与推荐

  • 依据ICM定义,4%(4/94)、15%(14/94)、14%(13/94)和67%(63/94)的患者分别为确定、很可能、可能或不太可能肩关节假体周围感染。

临床怎么用

  • D-二聚体可作为肩关节假体周围感染的辅助血清标志物,但单独诊断准确性有限。
  • 联合ESR、CRP和D-二聚体三项均阳性可提高特异性,但敏感性明显降低。

局限性

  • 证据等级为III级诊断性研究。
  • 样本来自单中心翻修肩关节置换患者,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The diagnosis of periprosthetic shoulder infection continues to be difficult to make with confidence. Serum D-dimer has proven to be effective as a screening tool for periprosthetic joint infection in other major joints; however, it has yet to be evaluated for use in periprosthetic shoulder infection. QUESTIONS/PURPOSES: (1) Is D-dimer elevated in patients with probable or definite periprosthetic shoulder infections? (2) What is the diagnostic accuracy of D-dimer for periprosthetic shoulder infections? (3) What are the diagnostic accuracies of serum tests (erythrocyte sedimentation rate [ESR], C-reactive protein [CRP], and D-dimer), singly and in combination? METHODS: Between March 2016 and March 2020, 94 patients undergoing revision total shoulder arthroplasty (anatomic or reverse) at a single institution had preoperative serum testing with CRP, ESR, and D-dimer. These 94 patients were a subset of 189 revision shoulder arthroplasties performed at this institution during the study period who met inclusion criteria and consented to participate. Included patients had a mean ± SD age of 69 ± 8 years, and 56% (53 of 94) were men. Patient records were reviewed to classify patients as definitely having infection, probably having infection, possibly having infection, or unlikely to have an infection, according to the International Consensus Meeting (ICM) definition of periprosthetic shoulder infection. Statistical analyses, including a receiver operating characteristic curve analysis, were performed to quantify the diagnostic value of D-dimer for periprosthetic shoulder infection. Based on the ICM definition, 4% (4 of 94), 15% (14 of 94), 14% (13 of 94), and 67% (63 of 94) of patients had definite, probable, possible, or unlikely periprosthetic shoulder infections. RESULTS: D-dimer was elevated in patients with definite or probable infections (median [range] 661 ng/mL [150 to 8205]) compared with those with possible infections or those who were unlikely to have an infection (263 ng/mL [150 to 3060]; median difference 143 ng/mL [95% CI 40 to 503]; p = 0.01). In the receiver operating characteristic curve analysis, D-dimer had an area under the curve of 0.71 (0.50-0.92), demonstrating weak diagnostic value. A D-dimer level of 598 ng/mL provided a sensitivity and specificity of 61% (95% CI 36% to 82%) and 74% (95% CI 62% to 83%), respectively, for diagnosing a definite or probable infection according to the ICM definitions. The specificity of detecting periprosthetic joint infection (88% [95% CI 79% to 94%]) was high when three positive serum markers (ESR, CRP, and D-dimer) were required, at the expense of sensitivity (28% [95% CI 10% to 53%]). CONCLUSION: In periprosthetic shoulder infection, D-dimer is elevated. However, similar to other serum tests, it has limited diagnostic utility in identifying patients with periprosthetic shoulder infection. Further work is needed to understand the process by which D-dimer is associated with active infection. LEVEL OF EVIDENCE: Level III, diagnostic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Zmistowski B, Chang M, Shahi A, et al. Is D-dimer a Reliable Serum Marker for Shoulder Periprosthetic Joint Infection? Clin Orthop Relat Res. 2021. PMID: 33929986. doi:10.1097/CORR.0000000000001774

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。